MediNatura New Mexico, Inc. has announced a voluntary nationwide recall of one lot of its ReBoost Nasal Spray as of December 10, 2025, due to microbial contamination detected during testing. The contamination includes Achromobacter and yeast/mold at levels surpassing acceptable limits, posing potentially serious health risks for immunocompromised individuals.
Key Points:
- The recall affects one lot of ReBoost Nasal Spray with lot number 224268 and an expiration date of December 2027.
- Microbial contamination could cause life-threatening infections in vulnerable populations.
- MediNatura urges customers to stop using the product and return it for a full refund.
Below, you’ll find everything you need to know about this recall, including affected products, health risks, and steps for consumers.
In this article:
- What products are affected?
- What are the health risks?
- What should consumers do?
- Frequently Asked Questions
- Conclusion
- Disclaimer
- FDA Announcement Link
What products are affected?
The recall specifically applies to ReBoost Nasal Spray used to alleviate nasal congestion, sinus headache, postnasal drip, and related symptoms. Details for the affected lot:
| Product | NDC Number | UPC Number | Lot Number | Expiration Date |
|---|---|---|---|---|
| ReBoost Nasal Spray | 62795-4005-9 | 787647 10186 3 | 224268 | 12/2027 |
The product is offered in a 20mL bottle packaged within a white and yellow carton and sold nationwide via retail and online platforms.
What are the health risks?
Contamination with Achromobacter and yeast/mold could lead to severe infections in immunocompromised individuals. Specific risks include:
- Respiratory infections
- Systemic infections
- Potentially life-threatening complications
To date, no adverse events have been reported. However, consumers who experience issues should consult their healthcare provider and report problems to the FDA’s MedWatch program.
What should consumers do?
MediNatura advises the following:
- Stop using the ReBoost Nasal Spray immediately.
- If purchased directly from MediNatura, contact recall@medinatura.com for a refund arrangement.
- Products bought at retail stores should be returned to the original place of purchase.
Consumers with additional questions can call MediNatura’s support line at 800-621-7644, Monday through Friday, 8:00 AM to 5:00 PM MST.
Frequently Asked Questions
- What symptoms should I watch for if I’ve used the product?
Immunocompromised individuals should monitor for signs of infection, including fever, respiratory issues, and unusual fatigue. - Can I get a replacement instead of a refund?
The recall is limited to refunds; replacements are not provided. - How do I report adverse reactions?
You can submit reports online through FDA’s MedWatch, or obtain a form via phone at 1-800-332-1088.
Conclusion
This recall highlights the importance of rigorous product testing and safety measures. Customers are urged to discontinue use of the affected lot and follow MediNatura’s guidance for refunds or returns. Reporting adverse reactions ensures proper regulatory oversight and public safety.
Disclaimer
This article is for informational purposes only and not intended as legal or medical advice. Always consult regulatory or legal experts for guidance specific to your situation.
FDA Announcement Link
For full information about the FDA announcement, see the link below.
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/medinatura-new-mexico-inc-issues-voluntary-nationwide-recall-reboost-nasal-spray-due-microbial